The kinase inhibitor dabrafenib halts progression of cerebral cavernous malformations in a BRAF-independent manner

JSON

Arce M, Huang H, Rorsman C, Erzar I, Oldenburg J, Sun Y, Smith R, Onyeogaziri FC, Barbera S, Ahlstrand FC, Ranefall P, Klemm A, Richards M, Dimberg A, Claesson-Welsh L, Magnusson PU

Sci. Transl. Med. 18 (872) - [2026-10-21; online 2026-10-21]

BioImage Informatics [Collaborative]

Bioinformatics (NBIS) [Collaborative]

DOI 10.1126/scitranslmed.adr0448

Crossref 10.1126/scitranslmed.adr0448